Literature DB >> 17095837

Contrast-enhanced ultrasound in the diagnosis of pancreatic tumors.

Steffen Rickes1, Klaus Mönkemüller, Peter Malfertheiner.   

Abstract

Echo-enhanced ultrasound is a newly available imaging modality for the evaluation of pancreatic lesions. Neoplasms of the pancreas tend to have a characteristic vascularization pattern. Adenocarcinomas are often hypovascularized as compared to the surrounding tissue. On the other hand, neuroendocrine tumors are hypervascularized lesions. Masses associated with pancreatitis have a different vascularization pattern depending on the degree of inflammation and necrosis. Cystadenomas frequently show many vessels along fibrotic strands. Data from prospective studies have demonstrated that based on these imaging criteria, the sensitivity and the specificity of echo-enhanced sonography in diagnosing the degree of differentiation of pancreatic masses are equal to, or greater than, 85% and 90%, respectively. In conclusion, pancreatic tumors have a different vascularization pattern in echo-enhanced ultrasound. These characteristics can be used with high a diagnostic accuracy for differentiation.

Entities:  

Mesh:

Year:  2006        PMID: 17095837

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  11 in total

1.  [Diagnosis of ileal carcinoid with contrast enhanced ultrasonic diagnosis].

Authors:  Steffen Rickes; Christine Uhle; Holger Neye; Daniel Ensberg; Peter Rauh
Journal:  Med Klin (Munich)       Date:  2009-07-15

Review 2.  Transabdominal ultrasonographic diagnosis of relatively rare pancreatic neoplasms.

Authors:  Senju Hashimoto; Kazunori Nakaoka; Hiroyuki Tanaka; Teiji Kuzuya; Naoto Kawabe; Mitsuo Nagasaka; Yoshihito Nakagawa; Ryoji Miyahara; Tomoyuki Shibata; Yoshiki Hirooka
Journal:  J Med Ultrason (2001)       Date:  2022-02-12       Impact factor: 1.314

3.  Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound.

Authors:  C F Dietrich; B Braden; M Hocke; M Ott; A Ignee
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-19       Impact factor: 4.553

4.  Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration.

Authors:  Jose-Celso Ardengh; Cesar-Vivian Lopes; Luiz-Felipe Pereira de Lima; Juliano-Rodrigues de Oliveira; Filadelfio Venco; Giulio-Cesare Santo; Jose-Luiz-Pimenta Modena
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

5.  Docetaxel-encapsulating small-sized polymeric micelles with higher permeability and its efficacy on the orthotopic transplantation model of pancreatic ductal adenocarcinoma.

Authors:  Yunfei Li; Peiran Li; Mingji Jin; Changgao Jiang; Zhonggao Gao
Journal:  Int J Mol Sci       Date:  2014-12-17       Impact factor: 5.923

6.  Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.

Authors:  Chuangen Guo; Xiao Chen; Zhongqiu Wang; Wenbo Xiao; Qidong Wang; Ke Sun; Xiaoling Zhuge
Journal:  Oncotarget       Date:  2017-06-27

7.  Autoimmune pancreatitis: Imaging features.

Authors:  Yi Dong; Mirko D'Onofrio; Michael Hocke; Christian Jenssen; Andrej Potthoff; Nathan Atkinson; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2018 May-Jun       Impact factor: 5.628

8.  Enhancement parameters of contrast-enhanced computed tomography for pancreatic ductal adenocarcinoma: Correlation with pathologic grading.

Authors:  Woorim Seo; Young Chul Kim; Seon Jeong Min; Sang Min Lee
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

9.  Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound.

Authors:  Michael Hocke; Christoph F Dietrich
Journal:  Int J Inflam       Date:  2012-07-10

10.  UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy.

Authors:  Lizhou Lin; Yu Fan; Feng Gao; Lifang Jin; Dan Li; Wenjie Sun; Fan Li; Peng Qin; Qiusheng Shi; Xiangyang Shi; Lianfang Du
Journal:  Theranostics       Date:  2018-02-14       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.